Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$70 n/a | n/a%
04/17/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 70.00
52 Week High 84.88
52 Week Low 46.70
Avg. Daily Vol. (Mil) 15.72
Beta (3 year) 0.93
Share Related Items
Mkt Cap (Mil) 107,649.74
Shares Out (Mil) 1,538.25
Float (Mil) 1,529.66
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.70
Current Ratio 1.10
LT Debt/ Equity 0.35
Total Debt / Equity 0.58
Valuation Ratios
Price Earnings 38.60
Price/Sales 9.61
Price/Book 9.47
Price/Cash Flow 31.70
Per Share Data
Earnings 1.81
Sales 7.28
Book Value 7.39
Cash Flow 2.21
Business Summary
Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.
General Information
333 Lakeside Drive
Foster City, CA 94404
www.gilead.com
Industry : Drugs
Sector: Health Care
Employees: 6100
CEO: Dr. John C. Martin,M.D.
Short Interest
Current Month (Mil) 91.77
Previous Month (Mil) 89.55
Short Interest Ratio (Days) 5.70
Management Effectiveness
Return on Equity 26.90
Return on Assets 13.60
Return on Investments 20.00
Profitability
Gross Margin 77.60
EBIT Margin 40.30
Profit Margin 27.30

Portfolios with GILD

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases

Partner Headlines for GILD

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter